Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.
Related Posts
Trump Organization Says Incoming President Will Separate Himself From Family Business
- staff
- January 10, 2025
- 0
The company is set to release a series of ethics rules governing Donald Trump’s interactions with his business empire.
Sonoco Products Buys Eviosys From KPS Capital For $3.9 Billion
Sonoco Products said it is buying Eviosys from KPS Capital Partners for around $3.9 billion as it seeks to be the leading metal food can […]
Dave & Buster’s Entertainment CEO Morris Resigns Amid Wider Losses, Sheehan Interim Replacement
Chris Morris’ exit comes as the company reports a significantly wider loss and lower revenue for its fiscal third quarter.